Related Experiment Video
Updated: Mar 11, 2026

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
MELAS Syndrome with Cardiac Involvement: A Multimodality Imaging Approach
Sara Seitun1, Laura Massobrio2, Anna Rubegni3
1Department of Radiology and Interventional Radiology, IRCCS AOU San Martino, IST Genova, Largo Benzi 10, 16100 Genova, Italy.
Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes syndrome (MELAS) can cause cardiac issues. A patient with MELAS and a specific mitochondrial DNA mutation (m.3243A>G) developed heart problems, requiring a defibrillator.
Area of Science:
- Cardiology
- Genetics
- Neurology
Background:
- Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes syndrome (MELAS) is a multisystem disorder.
- Cardiac involvement is a serious complication of MELAS, increasing mortality risk.
- Left ventricular hypertrophy and myocardial fibrosis are potential cardiac manifestations.
Purpose of the Study:
- To report a case of cardiac involvement in a patient with MELAS.
- To identify the genetic basis of cardiac symptoms in this patient.
- To highlight the importance of cardiac monitoring and management in MELAS.
Main Methods:
- Clinical presentation assessment including chest pain, dyspnea, and lactic acidosis.
- Cardiac evaluation including echocardiography to detect left ventricular hypertrophy and myocardial fibrosis.
- Mitochondrial genome sequencing to identify mutations in the mitochondrial DNA (mtDNA).
Main Results:
- The patient presented with symptoms suggestive of cardiac compromise.
- Mitochondrial genome sequencing identified the m.3243A>G point mutation in the tRNALeu(UUR) gene.
- The findings confirmed cardiac involvement secondary to MELAS.
Conclusions:
- The m.3243A>G mtDNA mutation is associated with cardiac manifestations in MELAS.
- Early diagnosis and management of cardiac complications are crucial in MELAS patients.
- Implantation of a cardioverter defibrillator is indicated in high-risk MELAS patients to prevent sudden cardiac death.
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System IV: CMRI
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy

